A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to Colonoscopy
- Registration Number
- NCT00885274
- Lead Sponsor
- Queen's University
- Brief Summary
Pico-Salax is an osmotic and stimulant bowel cleansing agent used prior to colonoscopy. It is unknown whether splitting the doses (i.e. taking the second dose the morning of the colonoscopy) results in a better bowel cleansing, as research with other agents suggests this may be the case. This study aims to assess whether splitting the dose of Pico-Salax results in a better bowel cleansing than traditional dosing.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
- colonoscopy indicated
Exclusion Criteria
- congestive heart failure
- ascites
- renal failure
- hyponatremia
- previous intestinal surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Split Dose Split Dose Pico-Salax Doses of Pico-Salax split: one dose administered the night prior to colonoscopy and the other dose administered the day of the procedure. Traditional Dose Pico-Salax Both doses of Pico-Salax taken the evening prior to colonoscopy.
- Primary Outcome Measures
Name Time Method bowel cleansing assessed by the Ottawa Bowel Preparation Scale day of colonoscopy
- Secondary Outcome Measures
Name Time Method patient tolerance of preparation day of colonoscopy
Trial Locations
- Locations (1)
Hotel Dieu Hospital
🇨🇦Kingston, Ontario, Canada